A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants

A Phase 1 Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SEP-479 in Healthy Adult Participants

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects of oral SEP-479 in healthy adult participants.

Inclusion Criteria:

1. Subjects who are able and willing to provide informed consent
2. Aged 21 to 60 years at the time of consent
3. Have a BMI within the range 18.0 to 32.0 kg/m2
4. In general good health

Exclusion Criteria:

1. Any condition, which in the investigator's opinion might jeopardize participant's safety or compliance with the protocol.
2. Have clinically significant abnormalities on clinical laboratory results.
3. Participation in other clinical trials recently/currently